期刊文献+

PREVENTING RESTENOSIS FOLLOWING PTCA

PREVENTING RESTENOSIS FOLLOWING PTCA
暂未订购
导出
摘要 Whether InfusaSleeve(IS) catheter can deliver antisense oligodeoxynucleotide (ODNs) following arterial denuation is unknown. We evaluate the feasibility of local endoluminal delivery of Cmyc ODNs to the site of arterial denudation by using IS catheter and to determine the biological importance of these effects. IS catheter was introduced into right side of iliac artery of 21 rabbits after angioplasty of iliac artery. Animals were randomized to the control group (n=6) receiving saline injection and the treated group receiving cmyc antisense (n=15, 1 mg ODNs per vessel). In two weeks and 40 days following the operation, angiography was performed. Morphometric analyses were carried out in balloondenuded iliac arteries. The expression of cmyc protein was detected by using a mouse monoclonal antibody to cmyc. Morphometric analyses carried out at 40 days after transcatheter cmyc antisense oligomer administration. The results showed that maximal neointimal area was reduced from 76637(105 m2) in the control group (n=6) to 404102(105 m2) in the antisense treated group (n=6, P<005). These changes in vascular remodeling following denuding injury resulted in an increase in residual luman from 2050% in the control group to 7090% in the antisensetreated group. Cmyc protein expression was virtually undetectable at baseline in locally ODNsdelivered arteries and detectable in control denuded arteries. The results show that: Single IS transcatheter administration allowed endoluminal delivery of ODNs to the site of arterial injury; cmyc antisense oligomer reduced the formation of neointime in denuded arteries, implying a therapeutic potential of this approach. Whether InfusaSleeve(IS) catheter can deliver antisense oligodeoxynucleotide (ODNs) following arterial denuation is unknown. We evaluate the feasibility of local endoluminal delivery of Cmyc ODNs to the site of arterial denudation by using IS catheter and to determine the biological importance of these effects. IS catheter was introduced into right side of iliac artery of 21 rabbits after angioplasty of iliac artery. Animals were randomized to the control group (n=6) receiving saline injection and the treated group receiving cmyc antisense (n=15, 1 mg ODNs per vessel). In two weeks and 40 days following the operation, angiography was performed. Morphometric analyses were carried out in balloondenuded iliac arteries. The expression of cmyc protein was detected by using a mouse monoclonal antibody to cmyc. Morphometric analyses carried out at 40 days after transcatheter cmyc antisense oligomer administration. The results showed that maximal neointimal area was reduced from 76637(105 m2) in the control group (n=6) to 404102(105 m2) in the antisense treated group (n=6, P<005). These changes in vascular remodeling following denuding injury resulted in an increase in residual luman from 2050% in the control group to 7090% in the antisensetreated group. Cmyc protein expression was virtually undetectable at baseline in locally ODNsdelivered arteries and detectable in control denuded arteries. The results show that: Single IS transcatheter administration allowed endoluminal delivery of ODNs to the site of arterial injury; cmyc antisense oligomer reduced the formation of neointime in denuded arteries, implying a therapeutic potential of this approach.
出处 《Journal of Pharmaceutical Analysis》 CAS 1999年第1期32-36,共5页 药物分析学报(英文版)
关键词 ANTISENSE OLIGODEOXYNUCLEOTIDE CMYC local delivery antisense oligodeoxynucleotide cmyc local delivery
  • 相关文献

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部